SCHEMBL18924485

SCHEMBL18924485

CC(C)(C)Cc1ccc(NC2CCCC2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.52
CYP11B2 P19099 1/20 0.52
HCAR3 P49019 3/20 0.50
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDE10A Q9Y233 2/20 0.39
NUDT1 P36639 1/20 0.37
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
PDGFRB P09619 2/20 0.37
PDGFRA P16234 2/20 0.37
MAP4K4 O95819 1/20 0.37
PRKAB2 O43741 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA2 P54646 1/20 0.36
PRKAA1 Q13131 1/20 0.36
PRKAG3 Q9UGI9 1/20 0.36
PRKAG2 Q9UGJ0 1/20 0.36
PRKAB1 Q9Y478 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13662094 0.81 HCAR3 (0.53) CYP11B1CYP11B2HCAR3KDM4EALDH1A1
SCHEMBL19891749 0.79 HCAR3 (0.50) CYP11B1CYP11B2HCAR3KDM4EALDH1A1
SCHEMBL508376 0.78 HCAR3 (0.53) CYP11B1CYP11B2HCAR3KDM4EALDH1A1
SCHEMBL8104999 0.78 HCAR3 (0.56) CYP11B1CYP11B2HCAR3KDM4EALDH1A1
SCHEMBL24415724 0.76 CYP11B1 (0.58) CYP11B1CYP11B2HCAR3KDM4EL3MBTL1
SCHEMBL12867094 0.75 HCAR3 (0.42) CYP11B1CYP11B2HCAR3ALDH1A1NUDT1
SCHEMBL13657974 0.75 HCAR3 (0.53) HCAR3KDM4EALDH1A1L3MBTL1PDE10A
SCHEMBL14217161 0.75 HCAR3 (0.52) CYP11B1CYP11B2HCAR3KDM4EALDH1A1
SCHEMBL22521538 0.74 LMNA (0.42) CYP11B1CYP11B2KDM4EALDH1A1L3MBTL1
SCHEMBL18924314 0.74 HCAR3 (0.46) CYP11B1CYP11B2HCAR3ALDH1A1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670172-B2 Heterocyclic compounds and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2017-06-06 US disclosed